Different forms of dysfunction of the lower urinary tract can be treated with electrical stimulation. Currently, two operative treatment modalities are available. In patients with spinal cord injury the combination of posterior sacral root rhizotomies with implantation of electrodes on the anterior roots produces excellent results in terms of restoration of continence and bladder evacuation. In patients with chronic problems of urge incontinence, urgency/frequency and voiding dysfunction, neuromodulation of a sacral nerve with an implantable system can reduce the symptomatology significantly. Both these treatments are a valuable addition to the modern neuro-urological practice.

Keywords:
Voiding dysfunction, Electrical stimulation
1.
Wein AJ, Raezer DM, Benson GS: Management of neurogenic bladder dysfunction in the adult. Urology 1976;8:432.
2.
Bradley WE, Timm GW, Chou SN: A decade of experience with electronic stimulation of the micturition reflex. Urol Int 1971;26:283.
3.
Godec C, Cass AS, Ayala GF: Electrical stimulation for incontinence: Technique, selection and results. Urology 1976;7:388.
4.
Merrill DC: The treatment of detrusor incontinence by electrical stimululation. J Urol 1979;122:515.
5.
Fall M: Does electrical stimulation control incontinence? J Urol 1984;131:664.
6.
Katona F: Stages of vegetative afferentiation in reorganization of bladder control during intravesical electrotherapy. Urol Int 1975;30:192.
7.
Seiferth J, Heising J, Larkamp H: Experiences and critical comments on the temporary intravesical electrostimulation of neurogenic bladder in spina bifida children. Urol Int 1978;33:27.
8.
Madersbacher H, Pauer W, Reiner E: Rehabilitation of micturition by transurethral electrostimulation of the bladder in patients with incomplete spinal cord lesions. Paraplegia 1982;20:191.
9.
Caldwell KPS: Urinary incontinence following spinal injury treated by electronic implant. Lancet 1985;i:846.
10.
Brindley GS, Polkey CE, Rushton DN, Cardozo L: Sacral anterior root stimulators for bladder control in paraplegia. The first 50 cases. J Neurol Neurosurg Psychiatry 1986;49:1104.
11.
Tanagho EA, Schmidt RA, Orvis BR: Neural stimulation for control of voiding dysfunction: A preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol 1989;142:340.
12.
Markland C, Merrill D, Chou S, Bradley W: Sacral nerve root stimulation: A clinical test of detrusor innervation. J Urol 1972;107:772.
13.
Schmidt RA: Advances in genitourinary neurostimulation. Neurosurgery 1986;18:1041.
14.
Brindley GS: Experiments directed towards a prosthesis which controls the bladder and the external sphincter from a single site of stimulation. Proc Biological Engineering Society, 46th Meeting, Liverpool 1972.
15.
Brindley GS, Polkey CE, Rushton DN: Sacral anterior root stimulation for bladder control in paraplegia. Paraplegia 1982;20:365.
16.
Sauerwein D: Die operative Behandlung der spastischen Blasenlähmung bei Querschnittlähmung. Urologe A 1990;29:196.
17.
Van Kerrebroeck PEV, Koldewijn EL, Wijkstra H, Debruyne FMJ: Intradural sacral rhizotomies and implantation of an anterior sacral root stimulator in the treatment of neurgenic bladder dysfunction after spinal cord injury. World J Urol 1991;9:126.
18.
Van Kerrebroeck PEV, Debruyne FMJ: World-wide experience with the Finetech-Brindley bladder stimulator. Neurourol Urodyn 1993;12:497–503.
19.
Van Kerrebroeck PhEV, Koldewijn EL, Rosier P, Wijkstra H, Debruyne FMJ: Results of the treatment of neurgenic bladder dysfunction in spinal cord injury by sacral posterior rooth rhizotomy and anterior sacral root stimulation. J Urol 1996;155:1378–1381.
20.
Van Kerrebroeck PhEV, van der Aa HE, Bosch JLHR, Koldewijn EL, Vorsteveld JHC, Debruyne FMJ, and the Dutch Study Group on Sacral Anterior Root Stimulation: Sacral Rhizotomies and Electrical Bladder Stimulation in Spinal Cord Injury. Clinical and urodynamic analysis. Eur Urol 1997;31:263–271.
21.
Wielink G, Essink-Bot ML, Van Kerrebroeck PhEV, Rutten FFH and the Dutch Study Group on Sacral Anterior Root Stimulation: Sacral Rhizotomies and Electrical Bladder Stimulation in Spinal Cord Injury. Cost-effectiveness and quality of life analysis. Eur Urol 1997;31:441–446.
22.
Brindley GS, Rushton DN: Long-term follow-up of patients with sacral anterior root stimulator implants. Paraplegia 1990;28:469.
23.
Habib HN: Experiences and recent contributions in sacral nerve stimulation for both human and animal. Br J Urol 1967;39:73.
24.
Schmidt RA: Applications of neurostimulation in urology. Neurourol Urodyn 1988;7:585.
25.
Thon WF, Baskin LS, Jonas U, Tanagho EA, Schmidt RA: Neuromodulation of voiding dysfunction and pelvic pain. World J Urol 1991;9:38.
26.
Bosch JLHR, Groen J: Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: Results of chronic electrical stimulation using an implantable neural prosthesis. J Urol 1995;154:504.
27.
Koldewijn EL, Rosier PFWM, Meuleman EJH, Koster AM, Debruyne FMJ, Van Kerrebroeck PhEV: Predictors of success with neuromodulation in lower urinary tract dysfunction. Results of trial stimulation in 100 patients. J Urol 1994;152:2071.
28.
Janknegt RA, Van Kerrebroeck PhEV, Lycklama à Nijeholt A, Schmidt RA, Hassouna MM, Siegel SW: Sacral nerve modulation for urge incontinence: A multinational, multicenter randomized study. J Urol 1997;157:1237.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.